Retinoic acid receptor α mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells

British Journal of Cancer

Volumn 78, Issue 10, 1998, Pages 1288-1295

  Brembeck, F H ^a   Kaiser, A ^a   Detjen, K ^a   Hotz, H ^b   Foitzik, T ^b   Buhr, H J ^b   Riecken, E O ^a   Rosewicz, S ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

All trans retinoic acid; Ductal pancreatic carcinoma; Retinoic acid receptor

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; LUCIFERASE; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DNA TRANSFECTION; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

EID: 0031787899     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.673     Document Type: Article

References (50)

1. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W and Klaus M (1992) A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89: 7129-7133
2. Bockman DE, Black Jr O, Mills LR, Mainz DL and Webster PD (1976) Fine structure of pancreatic adenocarcinoma induced in rats by 7.12-dimethylben(a)anthracene. J Natl Cancer Inst 57: 931-936
3. Bockman DE, Black Jr O, Mills LR and Webster PD (1978) Origin of tubular complexes developing during induction of pancreatic adenocarcinoma by 7.12-dimethylbenz(a)nthracene. Am J Pathol 90: 645-658
4. Bollag W (1983) Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1: 860-863
5. Bollag W and Holdener EE (1992) Retinoids in cancer prevention and therapy. Ann Oncol 3: 513-526
6. Brembeck FH, Schoppmeyer K, Leupold U, Gornistu C, Keim V, Mössner J, Riecken EO and Rosewicz S (1998) A phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma. (submitted)
7. Cerny WL, Mangold KA and Scarpelli DG (1990) Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Carcinogenesis 11: 2075-2079
8. Crettaz M, Baron A, Siegenthaler G and Hunziker W (1990) Ligand specificities of recombinant retinoic acid receptors RAR α and RAR β. Biochem J 272: 391-397
9. De Lisle RC and Logsdon CD (1990) Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur J Cell Biol 51: 64-75
10. Dissin J, Mills LR, Mains DL, Black Jr O and Webster PD (1975) Experimental induction of pancreatic adenocarcinoma in rats. J Natl Cancer Inst 55: 857-864
11. Dolle P, Ruberte E, Leroy P, Morriss-Kay G and Chambon P (1990) Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 110: 1133-1151
12. Durand B, Saunders M, Leroy P, Leid M and Chambon P (1992) All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell 71: 73-85
13. Forman BM, Umesono K, Chen J and Evans RM (1995) Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81: 541-550
14. Giguère V (1994) Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Rev 15: 61-79
15. Green S and Chambon P (1988) Nuclear receptors enhance our understanding of transcription regulation. Trends Biochem Sci 4: 309-314
16. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406
17. Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A, Leroy P, Staub A and Chambon P (1990) Murine isoforms of retinoic acid receptor γ with specific patterns of expression. Proc Natl Acad Sci USA 87: 2700-2704
18. Kim JH, Ho SB, Montgomery CK and Kim S (1990) Cell lineage markers in human pancreatic cancer. Cancer 66: 2134-2143
19. Kliewer SA, Umesono K, Mangelsdorf DJ and Evans RM (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446-449
20. Lee X, Si SP, Tsou HC and Peacocke M (1995) Cellular aging and transformation suppression: a role for retinoic acid receptor β 2. Exp Cell Res 218: 296-304
21. Leid M, Kastner P and Chambon P (1992a) Multiplicity generates diversity in the retinoic acid signaling pathway. Trends Biochem Sci 17: 427-433
22. Leid M, Kastner P, Lyons R, Naksharti H, Saunders M, Zacherewski T, Chen JY, Staub A, Garnier JM and Chambon P (1992b) Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimers bind target sequences effectively. Cell 68: 377-395
23. Lionetto R, Pugliese V, Bruzzi P and Rosso R (1995) No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 31A: 882-887
24. Longnecker DS and Curphey TJ (1975) Adenocarcinoma of the pancreas in azaserine-treated rats. Cancer Res 35: 2249-2258
25. Longnecker DS, Memoli V and Pettengill OS (1992) Recent results in animal models of pancreatic carcinoma: histogenesis of tumors. Yale J Biol Med 65: 457-164
26. Lotan R (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33-91
27. Lotan R, Lotan D and Sacks PG (1990) Inhibition of tumor eell growth by retinoids. Methods Enzymol 190: 100-110
28. Love JM and Gudas LJ (1994) Vitamin A, differentiation and cancer. Curr Opin Cell Biol 6: 825-811
29. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83: 841-850
30. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic aeid. Genes Dev 6: 329-344
31. Mangelsdorf DJ, Umesono K and Evans R (1994) The retinoid receptors. In The Retinoids: Biology, Chemistry and Medicine, 2nd edn. Mangelsdorf JE, Evans R (eds), pp. 319-349. Raven Press: New York
32. Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M and Norris MD (1995) Increased retinoic acid receptor γ expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene 11: 485-491
33. Moasser MM, DeBlasio A and Dmitrovsky E (1994) Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor γ in human teratocarcinomas. Oncogene 9: 833-840
34. Muindi JR, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW and Warrell Jr RP (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52: 2138-2142
35. Näär AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK and Rosenfeld MG (1991) The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65: 1267-1279
36. Pettengill OS, Faris RA, Bell Jr RH, Kuhlmann ET and Longnecker DS (1993) Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas. Am J Pathol 143: 292-303
37. Rosewicz S, Lewis LD, Wang XY, Liddle RA and Logsdon CD (1989) Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor. Am J Physiol 256: G733-738
38. Rosewicz S, Riecken EO and Wiedenmann B (1992a) The amphicrine pancreatic cell line AR42J: a model system for combined studies on exocrine and endocrine secretion. Clin Invest 70: 205-209
39. Rosewicz S, Vogt D, Harth N, Grund C, Franke WW, Ruppert S, Schweitzer E, Riecken EO and Wiedenmann B (1992b) An amphicrine pancreatic cell line AR42J cells combine exocrine and neuroendocrine properties. Eur J Cell Biol 59: 80-91
40. Rosewicz S, Detjen K, Kaiser A, Prosenc N, Cervos-Navarro J, Riecken EO and Haller H (1994) Bombesin receptor gene expression in rat pancreatic acinar AR42J cells: transcriptional regulation by glucocorticoids. Gastroenterology 107: 208-218
41. Rosewicz S, Stier U, Brembeck F, Kaiser A, Papadimitriou CA, Berdel WE, Wiedenmann B and Riecken EO (1995a) Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 109: 1646-1660
42. Rosewicz S, Riecken EO and Stier U (1995b) Transcriptional regulation of carbonic anhydrase II by retinoic acid in the human pancreatic tumor cell line DANG. FEBS Lett 368: 45-48
43. Satake K, Mukai R, Kato Y, Shim K and Umeyama K (1984) Experimental pancreatic carcinoma as a model of human pancreatic carcinoma. Clin Oncol 10: 27-34
44. Scarpelli DG, Rao MS and Reddy JK (1984) Studies of pancreatic carcinogenesis in different animal models. Environ Health Perspect 56: 217-227
45. Smith MA, Parkinson DR, Cheson BD and Friedman MA (1992) Retinoids in cancer therapy. J Clin Oncol 10: 839-864
46. Tallman MS and Wiernik PH (1992) Retinoids in cancer treatment. J Clin Pharmacol 32: 868-888
47. Umesono K, Murakami KK, Thompson CC and Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255-1266
48. van der Leede BJ, Folkers GE, van den Brink CE, van der Saag PT and van der Burg B (1995) Retinoic acid receptor α 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 109: 77-86
49. Xu XC, Stier U, Rosewicz S, El-Naggar AK and Lotan R (1996) Selective suppression of nuclear retinoic acid receptor β gene expression in human pancreatic carcinomas. Int J Oncol 8: 445-451
50. Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM, Ruffenach F, Leroy P and Chambon P (1991) Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing. EMBO J 10: 71-78